In spite of the huge advancements in both diagnosis and interventions. hormone refractory prostate cancer (HRPC) remains a major hurdle in prostate cancer (PCa). Metabolic reprogramming plays a key role in PCa oncogenesis and resistance. However. https://www.ngetikin.com/